Completed PHASE1 INTERVENTIONAL NCT00001605

Vaccination for Middle Ear Infection

Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions Otitis Media

Interventions Nontypeable Haemophilus influenzae

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: May 31, 1997 Completion: Apr 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Otitis Media and is currently completed. National Institute on Deafness and Other Communication Disorders (NIDCD) leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States